BellRing Brands (BRBR)
NYSEConsumer StaplesPackaged FoodsSnapshot 2026-09-04
NYSEConsumer StaplesPackaged FoodsSnapshot 2026-09-04
Research Workspace
Put BRBR beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Packaged Foods & Meats: fringe margins under pressure (0q confirmed)
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar broken — Adjusted EBITDA of $315-$335 million in FY26: FY26 Adj EBITDA guidance $275M-$295M vs target ~$325M.
View ThesisRevenue growth is slowing — up about 6% over the past year and decelerating.
View GrowthMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 3% on a typical day and fell roughly 80% in its worst 12-month stretch.
View RiskBRBR's growth relies on maintaining its earnings trajectory amid a challenging market backdrop. Revenue grew 4% year over year, but the latest quarter missed expectations. It trades at 7.9× P/E versus a peer median of 12.5×, indicating the price reflects less growth than anticipated. A specific risk is the elevated probability of a miss at 44%. Peer multiples imply a price about 61% above where it trades. Our read is provisional.
Trailing returns as of 2026-09-04. BRBR is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 14 analysts currently covering BRBR (as of Sep 2026).
Based on 3 Wall Street analysts offering 12-month price targets for BRBR in the last 4 months.
Continue this research
Compare BRBR with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| BRBR Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 8 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Packaged Foods & Meats — fair value, gap to price, and forward P/E.
Compare the value case
Put BRBR next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Revenue growth acceleration
Significant stock drop indicates market concerns.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-04. EPS is implied from price ÷ P/E. Not investment advice.
Current $10.39
The last 12 months of price, then the range of analyst 12-month targets from today’s $10.39.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Revenue growth acceleration
Revenue growth reported despite margin pressures.
Threatens: Revenue growth acceleration
Sales outlook cut raises concerns about growth.
Threatens: Revenue growth acceleration
Price target cut indicates competitive pressures.